glp-1 medication long term side effects Adverse of class drugs. Gastrointestinal issues are GLP-1 medications can support weight

Description

The SELECT trial, completed in 2023 with over 17,600 participants, showed a 20% reduction in cardiovascular events in patients with established cardiovascular disease and overweight or obesity without diabetes

Study Objectives To evaluate if semaglutide 2.4 mg subcutaneously once weekly is superior to placebo when added to standard of care for preventing major adverse cardiovascular events in patients with established CVD and overweight or obesity but without diabetes

The Precision Peptide Genetic Test reveals predispositions in key peptide pathway variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may influence how your body responds to GLP-1 activation

Medications such as Contrave and Qsymia can be effective for treatment. If you cant afford your GLP-1 medication without insurance, talk to your healthcare provider about some alternatives: Qsymia (phentermine-topiramate), an appetite suppressant available as a once-daily oral capsule Contrave (naltrexone-bupropion), an oral tablet typically taken twice per day to manage cravings and reduce appetite Adipex-P (phentermine), an appetite-suppressing tablet typically taken once per day Diethylpropion extended-release, a long-lasting appetite-suppressing tablet typically taken once per day Phendimetrazine tartrate, available as a tablet thats taken before meals (up to three times per day) to increase the bodys metabolism and reduce appetite Alli (orlistat), an oral capsule that limits how much fat the body absorbs and can be taken up to three times per day, about an hour before eating Xenical (orlistat), a capsule that contains the same active ingredient as Alli but in a higher dose Your healthcare provider may also prescribe a generic GLP-1 agonist: liraglutide or exenatide